Long Island Center for Recovery Inc Inpatient Rehabilitation Program

Long Island Center for Recovery Inc Inpatient Rehabilitation Program

Services:
Opioid Medications used in Treatment
• Naltrexone used in Treatment
• Buprenorphine used in Treatment

Recovery Support Services

• Housing services
• Self-help groups

Other Services

• Treatment for gambling disorder
• Treatment for other addiction disorder

Age Groups Accepted

• Adults
• Young Adults

Gender Accepted

• Female
• Male

Medical Services

• Hepatitis A (HAV) vaccination
• Hepatitis B (HBV) vaccination

Facility Operation (e.g., Private, Public)

• Private for-profit organization

Facility Vaping Policy

• Vaping not permitted

Type of Opioid Treatment

• Prescribes naltrexone
• Prescribes buprenorphine
• Relapse prevention with naltrexone
• Accepts clients using MAT but prescribed elsewhere

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Residential/24-hour residential
• Short-term residential

Ancillary Services

• Mental health services
• Transportation assistance
• Case management service
• Social skills development

Education and Counseling Services

• Hepatitis education, counseling, or support
• Group counseling
• Health education services other than HIV/AIDS or hepatitis
• Marital/couples counseling
• Smoking/vaping/tobacco cessation counseling
• Family counseling
• Individual counseling
• Substance use disorder education
• HIV or AIDS education, counseling, or support

External Source of Medications Used for Alcohol Use Disorder Treatment

• No formal relationship with prescribing entity
• In-network prescribing entity

Payment/Insurance/Funding Accepted

• Private health insurance
• Cash or self-payment
• Medicaid

Type of Care

• Substance use treatment

License/Certification/Accreditation

• The Joint Commission
• State Substance use treatment agency

Facility Smoking Policy

• Smoking not permitted

Type of Alcohol Use Disorder Treatment

• Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
• This facility administers/prescribes medication for alcohol use disorder

Assessment/Pre-treatment

• Screening for tobacco use
• Screening for substance use
• Screening for mental disorders
• Comprehensive substance use assessment

Testing

• Metabolic syndrome monitoring
• Breathalyzer or blood alcohol testing
• Testing for Hepatitis B (HBV)
• Testing for Hepatitis C (HCV)
• STD testing
• Drug or alcohol urine screening
• HIV testing
• TB screening

Treatment Approaches

• Matrix Model
• Relapse prevention
• Substance use disorder counseling
• Trauma-related counseling
• 12-step facilitation

Pharmacotherapies

• Nicotine replacement
• Buprenorphine with naloxone
• Clonidine
• Medications for pre-exposure to prophylaxis
• Buprenorphine without naloxone
• Medications for Hepatitis C treatment
• Naltrexone (extended-release, injectable)
• Acamprosate (Campral®)
• Medication for mental disorders
• Naltrexone (oral)
• Disulfiram
• Non-nicotine smoking/tobacco cessation
• Medications for HIV treatment
• Buprenorphine (extended-release, injectable)

Special Programs/Groups Offered

• Clients with HIV or AIDS
• Members of military families
• Criminal justice (other than DUI/DWI)/Forensic clients
• Young adults
• Clients with co-occurring mental and substance use disorders
• Veterans
• Adult women
• Clients who have experienced trauma
• Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
• Clients who have experienced sexual abuse
• Adult men
• Clients who have experienced intimate partner violence, domestic violence
• Pregnant/postpartum women
• Clients with co-occurring pain and substance use disorders
• Seniors or older adults
• Active duty military

External Opioid Medications Source

• In-network prescribing entity
• No formal relationship with prescribing entity

Transitional Services

• Outcome follow-up after discharge
• Naloxone and overdose education
• Discharge Planning
• Aftercare/continuing care